logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 6 of 6 Items
Showing 1 - 6 of 6 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Conference Material
|
Poster

Scaling up cervical cancer screening in southern Malawi: Screening models for difficult-to-reach populations

Haider A, Goossens S, Desforges C, Chilinda G, Osman H,  et al.
2024-11-12 • International Papillomavirus 2024
2024-11-12 • International Papillomavirus 2024
Conference Material
|
Abstract

Scaling up cervical cancer screening in Southern Malawi: Screening models for difficult-to-reach populations

Haider A, Goossens S, Desforges C, Chilinda G, Osman H,  et al.
2024-11-12 • International Papillomavirus 2024
2024-11-12 • International Papillomavirus 2024

INTRODUCTION

MSF is providing cervical cancer screening in Blantyre and Chiradzulu districts in Southern Malawi in the catchment area of 10 health centres. Impr...

Journal Article
|
Research

Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.

Huerga H, Rucker SCM, Cossa L, Bastard M, Amoros I,  et al.
2019-04-30 • PLOS Medicine
2019-04-30 • PLOS Medicine
BACKGROUND:
Current guidelines recommend the use of the lateral flow urine lipoarabinomannan assay (LAM) in HIV-positive, ambulatory patients with signs and symptoms of tuberculosis...
Journal Article
|
Research

Should urine-LAM tests be used in TB symptomatic HIV-positive patients when no CD4 count is available? A prospective observational cohort study from Malawi

Huerga H, Rucker SCM, Bastard M, Dimba A, Kamba C,  et al.
2020-01-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2020-01-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
Background: Current eligibility criteria for urine lateral-flow-lipoarabinomannan assay (LF-LAM) in ambulatory, HIV-positive patients rely on the CD4 count. We investigated the diagnosti...
Journal Article
|
Research

Feasibility of using Determine TB-LAM to diagnose tuberculosis in HIV-positive patients in programmatic conditions: a multisite study

Cossa L, Harrison RE, Mpunga J, Lobo S, Kisaka Kimupelenge P,  et al.
2019-10-15 • Global Health Action
2019-10-15 • Global Health Action
Background: Determine TB-LAM is a urine-based point-of-care assay for diagnosis of tuberculosis (TB).
Objective: To assess the feasibility of using LAM to diagnose TB in adult HIV-...
Journal Article
|
Research

Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi

Nicholas S, Poulet E, Wolters L, Wapling J, Rakesh A,  et al.
2019-08-01 • Journal of the International AIDS Society
2019-08-01 • Journal of the International AIDS Society
INTRODUCTION:
Routinely monitoring the HIV viral load (VL) of people living with HIV (PLHIV) on anti-retroviral therapy (ART) facilitates intensive adherence counselling and faster ...